Related articles

• Comparative Study

  Does XR injectable naltrexone prevent relapse as effectively as daily sublingual buprenorphine-naloxone?

  J Fam Pract. 2020 Dec 1; 69 (10): E14-E15.

• Article

  Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.

  J Subst Abuse Treat. 2018 Feb 1; 85: 90-96.

• Case Reports

  Rapid micro-induction of buprenorphine/naloxone for opioid use disorder in an inpatient setting: A case series.

  Am J Addict. 2019 Jul 1; 28 (4): 262-265.

Show more related articles...